Phiusion Labs Inc. Announces Strategic Distribution Partnership with Proteos Biotech S.L. for PBSerum® in the United States and Canada April 13, 2026
AbbVie Showcases Late‑Breaking Phase 2 Data for Mirvetuximab Soravtansine-gynx (ELAHERE®) in Platinum‑Sensitive Ovarian Cancer (PSOC) at SGO 2026 April 13, 2026
Trinchero Family Wine & Spirits Accelerates Non-Alcoholic Leadership Through Exclusive Partnership with Libby April 10, 2026
Foundayo™ (orforglipron), Lilly’s new oral GLP-1 pill for weight loss, now available in the U.S. April 9, 2026
Books-A-Million Celebrates Associate Creativity and Announces Winners of Fourth Annual Round Up For Writers Contest; Customers Help Raise More Than $200,000 for Poets & Writers April 2, 2026
COMPLEX JOINS FANATICS SPORTSBOOK & FANATICS MARKETS TO REDEFINE SPORTS BETTING AND TRADING MEDIA WITH LAUNCH OF COMPLEX BETS, A NEW CULTURE-DRIVEN SPORTS BETTING AND TRADING PLATFORM April 2, 2026
Wegovy® pill demonstrated greater weight loss than orforglipron and lower odds of stopping medication due to side effects in a new indirect comparison to be presented at Obesity Medicine Association 2026 April 2, 2026